Commentary of the mRNA vaccines COVID-19

被引:1
作者
Antonio Vitiello [1 ]
Francesco Ferrara [1 ]
机构
[1] Pharmaceutical Department
关键词
D O I
暂无
中图分类号
R392-33 [免疫学技术、设备及实验方法];
学科分类号
100102 ;
摘要
The World Health Organization (WHO) declared global SARS-Co V-2 (COVID-19) pandemic status on March 11,2020[1].To date,data record approximately 106 million infected individuals and 2.32 million deaths due to pandemic COVID-19,worldwide.The most common symptoms of SARS-Co V-2infection reported are:elevation of body temperature,fatigue,cough,loss of smell.In a percentage of patients,
引用
收藏
页码:531 / 532
页数:2
相关论文
共 9 条
[1]   Drugs acting on the renin-angiotensin system and SARS-CoV-2 [J].
Vitiello, Antonio ;
Pelliccia, Chiara ;
Ferrara, Francesco .
DRUG DISCOVERY TODAY, 2021, 26 (04) :870-874
[2]  
COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission[J] . Bleier Benjamin S,Ramanathan Murugappan,Lane Andrew P.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery . 2020
[3]  
Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19[J] . A. Vitiello,F. Ferrara.Life Sciences . 2020
[4]  
Remdesivir versus ritonavir/lopinavir in COVID-19 patients[J] . Vitiello Antonio,Ferrara Francesco.Irish journal of medical science . 2020 (prep)
[5]  
Vaccines against COVID-19[J] . LOCHT Camille.Anaesthesia Critical Care & Pain Medicine . 2020 (prep)
[6]  
Remdesivir as a possible therapeutic option for the COVID-19[J] . Jaffar A. Al-Tawfiq,Ali H. Al-Homoud,Ziad A. Memish.Travel Medicine and Infectious Disease . 2020 (prep)
[8]   Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab [J].
Wijnsma, Kioa Lente ;
ter Heine, Rob ;
Moes, Dirk Jan A. R. ;
Langemeijer, Saskia ;
Schols, Saskia E. M. ;
Volokhina, Elena. B. ;
van den Heuvel, Lambertus P. ;
Wetzels, Jack F. M. ;
van de Kar, Nicole C. A. J. ;
Bruggemann, Roger J. .
CLINICAL PHARMACOKINETICS, 2019, 58 (07) :859-874
[9]  
Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine .2 POLACK F P,THOMAS S J,KITCHIN N,et al. N Engl JMed . 2020